Literature DB >> 16257460

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography.

Jan-Peter Smedema, Rene Truter, Petra A de Klerk, Leonie Zaaiman, Leonie White, Anton F Doubell.   

Abstract

Sarcoidosis is a multi-system granulomatous disorder of unknown etiology with symptomatic cardiac involvement in up to 7% of patients. The clinical features of sarcoid heart disease include congestive heart failure, arrhythmias, conduction disturbances, and sudden death. We evaluated the value of contrast-enhanced multi-detector computed tomography in delineating myocardial scar and granulomatous inflammation by comparing our findings with gadolinium magnetic resonance in a patient diagnosed with cardiac sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257460     DOI: 10.1016/j.ijcard.2005.07.059

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!

Authors:  Ahmed Aljizeeri; Abdulbaset Sulaiman; Naji Alhulaimi; Ahmed Alsaileek; Mouaz H Al-Mallah
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 2.  Advanced imaging of cardiac sarcoidosis.

Authors:  Chadi Ayoub; Elena Pena; Hiroshi Ohira; Alexander Dick; Eugene Leung; Pablo B Nery; David Birnie; Rob S B Beanlands
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 3.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 4.  Advances in clinical applications of cardiovascular magnetic resonance imaging.

Authors:  W P Bandettini; A E Arai
Journal:  Heart       Date:  2008-01-20       Impact factor: 5.994

Review 5.  CT imaging of myocardial viability: experimental and clinical evidence.

Authors:  Andreas H Mahnken; Georg Mühlenbruch; Rolf W Günther; Joachim E Wildberger
Journal:  Cardiovasc J Afr       Date:  2007 May-Jun       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.